Literature DB >> 29728953

Electrocardiography based prediction of hypertrophy pattern and fibrosis amount in hypertrophic cardiomyopathy: comparative study with cardiac magnetic resonance imaging.

Chul Hwan Park1, Hyemoon Chung2, Yoonjung Kim3, Jong-Youn Kim4, Pil-Ki Min4, Kyung-A Lee3, Young Won Yoon4, Tae Hoon Kim1, Byoung Kwon Lee4, Bum-Kee Hong4, Se-Joong Rim4, Hyuck Moon Kwon4, Eui-Young Choi5.   

Abstract

Although, cardiac magnetic resonance imaging (CMR) is a gold standard for risk stratification of hypertrophic cardiomyopathy (HCM), is limited in some situations. We sought to evaluate the predictive power of quantitative electrocardiography in assessing hypertrophy pattern and fibrosis in HCM. Eighty-eight patients with HCM were studied. Voltage of R-S-T waves, number of fragmented QRS (fQRS) complexes, and T wave morphology were measured by 12-lead electrocardiography. Sixteen segmental thickness, late gadolinium enhancement (LGE), native T1, extracellular volume fraction (ECV), and T2, left ventricular (LV) mass and %LGE were measured by CMR. Patterns of LV hypertrophy were classified as pure apical, mixed, or asymmetrical septal hypertrophy. Positive and negative predictive values of biphasic T wave for pure apical type were 70.4 and 63.9%, and the predictive values of precordial negative T wave sums [Formula: see text] 12.5 mm were 69.2 and 79.6%. Precordial S waves, especially Cornell voltage index, were significantly correlated to LV mass index and maximal thickness (p [Formula: see text]0.001). The number of fQRS leads was significantly correlated to %LGE, average ECV, and T2 (all p [Formula: see text]0.001). More than one lead with fQRS could predict [Formula: see text]5% of LGE mass with 58% sensitivity and 63% specificity (p = 0.049, area under the curve = 0.627). However, degree of correlation between maximal thickness and precordial S was poor in cases with fQRS more two leads. T wave morphology and precordial S helps discriminate hypertrophy pattern and maximal hypertrophy, however, in cases with more than two leads of concomitant fQRS, CMR defines fibrosis amount and hypertrophy more accurately.

Entities:  

Keywords:  Cardiac magnetic resonance imaging; Electrocardiography; Fibrosis; Hypertrophic cardiomyopathy

Mesh:

Substances:

Year:  2018        PMID: 29728953     DOI: 10.1007/s10554-018-1365-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  28 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

Review 2.  ST-segment depression and T-wave inversion: classification, differential diagnosis, and caveats.

Authors:  Elias B Hanna; David Luke Glancy
Journal:  Cleve Clin J Med       Date:  2011-06       Impact factor: 2.321

3.  A point-score system for the ECG diagnosis of left ventricular hypertrophy.

Authors:  D W Romhilt; E H Estes
Journal:  Am Heart J       Date:  1968-06       Impact factor: 4.749

4.  Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impending myocardial infarction.

Authors:  C de Zwaan; F W Bär; H J Wellens
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

5.  Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy.

Authors:  D Levy; S B Labib; K M Anderson; J C Christiansen; W B Kannel; W P Castelli
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

6.  Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.

Authors:  Gil Moravsky; Efrat Ofek; Harry Rakowski; Jagdish Butany; Lynne Williams; Anthony Ralph-Edwards; Bernd J Wintersperger; Andrew Crean
Journal:  JACC Cardiovasc Imaging       Date:  2013-04-10

7.  Comparison of the clinical features of apical hypertrophic cardiomyopathy versus asymmetric septal hypertrophy in Korea.

Authors:  Hyun Suk Yang; Jae-Kwan Song; Jong-Min Song; Duk-Hyun Kang; Cheol Whan Lee; Myeong-Ki Hong; Jae-Joong Kim; Seong-Wook Park; Seung-Jung Park
Journal:  Korean J Intern Med       Date:  2005-06       Impact factor: 2.884

8.  Diagnosis of acute global myocarditis using cardiac MRI with quantitative t1 and t2 mapping: case report and literature review.

Authors:  Chul Hwan Park; Eui-Young Choi; Andreas Greiser; Mun Young Paek; Sung Ho Hwang; Tae Hoon Kim
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

9.  Successful Evaluation of Biphasic T-wave of Wellens Syndrome in the Emergency Department.

Authors:  Ali Attila Aydin; Kemal Türker Ulutas; Cemile Aydin; Murtaza Kaya; Umut Akar; Tayfun Ture
Journal:  Acta Inform Med       Date:  2016-02-02

Review 10.  Repolarization Heterogeneity: Beyond the QT Interval.

Authors:  Stuart B Prenner; Sanjiv J Shah; Jeffrey J Goldberger; Andrew J Sauer
Journal:  J Am Heart Assoc       Date:  2016-04-29       Impact factor: 5.501

View more
  6 in total

1.  High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.

Authors:  Anna Wålinder Österberg; Ingegerd Östman-Smith; Robert Jablonowski; Marcus Carlsson; Henrik Green; Cecilia Gunnarsson; Petru Liuba; Eva Fernlund
Journal:  Pediatr Cardiol       Date:  2021-01-30       Impact factor: 1.655

2.  How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  Zsofia Dohy; Andras Vereckei; Viktor Horvath; Csilla Czimbalmos; Liliana Szabo; Attila Toth; Ferenc I Suhai; Ibolya Csecs; David Becker; Bela Merkely; Hajnalka Vago
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-04-23       Impact factor: 1.468

3.  Left Ventricular Dimension after Mitral Valve Surgery in Rheumatic Mitral Stenosis: The Impact of Myocardial Fibrosis.

Authors:  Teuku Muhammad Haykal Putra; Renan Sukmawan; Dwita Rian Desandri; Celly A Atmadikoesoemah; Elen Elen; Manoefris Kasim
Journal:  J Tehran Heart Cent       Date:  2020-07

4.  Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Authors:  Hyemoon Chung; Yoonjung Kim; Chul-Hwan Park; Jong-Youn Kim; Pil-Ki Min; Young Won Yoon; Tae Hoon Kim; Byoung Kwon Lee; Bum-Kee Hong; Se-Joong Rim; Hyuck Moon Kwon; Kyung-A Lee; Eui-Young Choi
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-04       Impact factor: 5.364

5.  Association of electrocardiographic markers with myocardial fibrosis as assessed by cardiac magnetic resonance in different clinical settings.

Authors:  George Bazoukis; Sebastian Garcia-Zamora; Göksel Çinier; Sharen Lee; Enes Elvin Gul; Jesús Álvarez-García; Gabi Miana; Mert İlker Hayıroğlu; Gary Tse; Tong Liu; Adrian Baranchuk
Journal:  World J Cardiol       Date:  2022-09-26

6.  Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.

Authors:  G J H Snel; M van den Boomen; L M Hernandez; C T Nguyen; D E Sosnovik; B K Velthuis; R H J A Slart; R J H Borra; N H J Prakken
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.